Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Post by jasonvnoon Nov 08, 2013 11:36pm

363 Views

Post# 21890934

FDA Approval Confirmation and Financing

As you can see I've been driven crazy with adrenaline in researching this stock. It has all the bells and whistles needed to grab your attention, AND the proof. Here's a powerpoint from the company, it's worth a full read as it holds pertinent information regarding Phase 3 trial results, potential market that cannot be shared with other companies due to the lack of competition, and general information about the company and what it is trying to accomplish.

Please rate post

https://www.spectraldx.com/presentations/SDI-Wedbush-2013.pdf

Bullboard Posts

Dynamic Funds Launches new ETF series on the TSX